'Hypoxio-spondin': thrombospondin and its emerging role in pulmonary hypertension

Affiliations

¹ Division of Pulmonary and Critical Care Medicine, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA.
² The Keenan Research Centre for Biomedical Science, St. Michael's Hospital, 209 Victoria Street, Toronto, ON, Canada M5B 1W8 Departments of Surgery and Physiology, University of Toronto, Toronto, ON, Canada Institute of Physiology, Charité - Universitaetsmedizin Berlin, Berlin, Germany German Heart Institute Berlin, Berlin, Germany kueblerw@smh.ca.

Editorial

Larissa A Shimoda et al. Cardiovasc Res. 2016.

. 2016 Jan 1;109(1):1-3.

doi: 10.1093/cvr/cvv258. Epub 2015 Nov 24.

¹ Division of Pulmonary and Critical Care Medicine, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA.
² The Keenan Research Centre for Biomedical Science, St. Michael's Hospital, 209 Victoria Street, Toronto, ON, Canada M5B 1W8 Departments of Surgery and Physiology, University of Toronto, Toronto, ON, Canada Institute of Physiology, Charité - Universitaetsmedizin Berlin, Berlin, Germany German Heart Institute Berlin, Berlin, Germany kueblerw@smh.ca.

No abstract available

Comment on

HIF-2α-mediated induction of pulmonary thrombospondin-1 contributes to hypoxia-driven vascular remodelling and vasoconstriction.
Labrousse-Arias D, Castillo-González R, Rogers NM, Torres-Capelli M, Barreira B, Aragonés J, Cogolludo Á, Isenberg JS, Calzada MJ. Labrousse-Arias D, et al. Cardiovasc Res. 2016 Jan 1;109(1):115-30. doi: 10.1093/cvr/cvv243. Epub 2015 Oct 26. Cardiovasc Res. 2016. PMID: 26503986 Free PMC article.